一项关于0.05%丙酸氯倍他索治疗白癜风的双盲试验。

Br J Dermatol. 1977 Jan;96(1):71-3. doi: 10.1111/j.1365-2133.1977.tb05188.x.

0-05% clobetasol proprionate (CP) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Twelve of twenty-three patients partially repigmented during 4 months' treatment with CP. All patients showed dermal atrophy with the CP.

0.05%丙酸氯倍他索（CP）的专利乳膏基质在白癜风治疗中显著优于单纯的乳膏基质。23名患者中有12名在使用CP治疗4个月期间出现部分色素再生。所有患者使用CP后均出现皮肤萎缩。